COVID-19 epidemic: anticoagulants treatments, another victim

Frédéric LapostolleSAMU 93 – UF Recherche-Enseignement-Qualité, Université Paris 13, Sorbonne Paris Cité, Inserm U942, Hôpital Avicenne, Bobigny, FranceCorrespondence[email protected]

Isabelle VianuSAMU 93 – UF Recherche-Enseignement-Qualité, Université Paris 13, Sorbonne Paris Cité, Inserm U942, Hôpital Avicenne, Bobigny, France

Tomislav PetrovicSAMU 93 – UF Recherche-Enseignement-Qualité, Université Paris 13, Sorbonne Paris Cité, Inserm U942, Hôpital Avicenne, Bobigny, France

Frédéric AdnetSAMU 93 – UF Recherche-Enseignement-Qualité, Université Paris 13, Sorbonne Paris Cité, Inserm U942, Hôpital Avicenne, Bobigny, France

References

Piccolo R, Bruzzese D, Mauro C, et al. Population trends in rates of percutaneous coronary revascularization for acute coronary syndromes associated with the COVID-19 outbreak. Circulation. 2020;141:2035–2037.
PubMed Web of Science ®Google Scholar
Yousefzai R, Bhimaraj A. Misdiagnosis in the COVID era: when zebras are everywhere, don’t forget the horses. JACC Case Rep. 2020;2(10):1614–1619.
Google Scholar
Søreide K, Hallet J, Matthews JB, et al. Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. Br J Surg. 2020;30. doi:10.1002/bjs.11670
Google Scholar
Nuti SV, Wayda B, Ranasinghe I, et al. The use of google trends in health care research: a systematic review. PLoS One. 2014;9(10):e109583.
PubMed Web of Science ®Google Scholar
Liu M, Caputi TL, Dredze M, et al. Internet searches for unproven COVID-19 therapies in the United States. JAMA Intern Med. 2020;180(8):1116.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

COVID-19 epidemic: anticoagulants treatments, another victim

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

COVID-19 epidemic: anticoagulants treatments, another victim

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date